文献速递临床试验与 GCP

局部麻醉下牙周基础治疗联合病灶内注射磷酸倍他米松治疗糜烂型口腔扁平苔藓的疗效与安全性:多中心、分口、随机自身对照试验研究方案

Efficacy and safety of periodontal initial therapy combined with intralesional betamethasone sodium phosphate injection under local anesthesia in managing erosive oral lichen planus: study protocol for a multi-center, split-mouth, randomized self-controlled trial.
PubMed 文献 · Trials · 2025-12-22

本研究为多中心、随机、分口、自身对照试验,计划在中国5家三级中心招募29例成人糜烂型牙龈口腔扁平苔藓伴广泛性牙周炎(II-IV期)患者。口内随机分配试验侧(局部麻醉下牙周基础治疗联合病灶内注射磷酸倍他米松)与对照侧(仅病灶内注射磷酸倍他米松),随访6个月,主要结局为第12周糜烂病变面积缩小。

要点

  • 试验侧为局部麻醉下牙周基础治疗联合病灶内注射磷酸倍他米松,对照侧仅注射磷酸倍他米松。
  • 计划招募29例成人糜烂型牙龈口腔扁平苔藓伴广泛性牙周炎(II-IV期)患者。
  • 主要结局为第12周糜烂病变面积缩小,随访6个月。

核心结论

  • 该研究方案旨在评估局部麻醉下牙周基础治疗联合病灶内注射磷酸倍他米松治疗糜烂型口腔扁平苔藓伴牙周炎的有效性和安全性,以期提供更有效且以患者为中心的多学科治疗策略。

研究设计与样本

  • 多中心、随机、分口、自身对照试验,计划在中国5家三级中心招募29例成人(年龄≥18岁)糜烂型牙龈口腔扁平苔藓伴广泛性牙周炎(II-IV期)患者。
  • 口内随机分配试验侧(局部麻醉下牙周基础治疗联合病灶内注射磷酸倍他米松)与对照侧(仅病灶内注射磷酸倍他米松),独立结局评估者和统计师严格盲法。
  • 随访6个月,在第2、4、8、12、24周进行评估。

主要发现

  • 主要结局为第12周糜烂病变面积缩小。
  • 次要结局包括完全愈合率、口腔扁平苔藓临床严重程度评分、疼痛视觉模拟评分、牙周参数和并发症。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Erosive oral lichen planus (OLP) and periodontitis frequently coexist and may worsen each other. This study will evaluate the effectiveness and safety of combining periodontal initial therapy under local anesthesia with intralesional betamethasone sodium phosphate (BSP) injection in patients with erosive OLP, particularly in enhancing lesion healing. METHODS AND ANALYSIS: This is a multicenter, randomized, split-mouth, self-controlled trial. We will recruit 29 adults from five tertiary centers in China. Eligible participants are adults (aged ≥ 18 years) diagnosed with erosive gingival OLP accompanied by generalized periodontitis (stage II-IV). Within each participant, sides will be randomly allocated to a test side (periodontal initial therapy under local anesthesia plus intralesional BSP) and a control side (intralesional BSP alone). Independent outcome assessors and statisticians will be strictly blinded to ensure objectivity of the assessments. The follow-up will last 6 months, with assessments at the 2nd, 4th, 8th, 12th, and 24th weeks. The primary outcome is the reduction in erosive lesion size at the 12th week. Secondary outcomes will include the complete healing rate, OLP clinical severity scores, visual analog score of pain, periodontal parameters, and complications. DISCUSSION: This protocol introduces an innovative method for managing erosive OLP accompanied by periodontitis by integrating periodontal initial therapy under local anesthesia with corticosteroid injections. It aims to offer a more effective and patient-centric multidisciplinary treatment strategy. The utilization of local anesthetics will enhance patient comfort and optimize adherence. Findings will guide clinical practice and motivate mechanistic studies. TRIAL REGISTRATION: The trial has been registered on the Chinese Clinical Trial Registry (No. ChiCTR2400083728; registered on April 30, 2024) and on the U.S. National Institutes of Health Clinical Trials website (No. NCT06498180; registered on July 12, 2024). PROTOCOL VERSION: 1.0 Version date: 01 September 2025.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Chen H, Shi L, Shang Q, et al. Efficacy and safety of periodontal initial therapy combined with intralesional betamethasone sodium phosphate injection under local anesthesia in managing erosive oral lichen planus: study protocol for a multi-center, split-mouth, randomized self-controlled trial. Trials. 2025. PMID: 41430296. doi:10.1186/s13063-025-09340-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。